Home › Funds › Catalio Capital Management, LP › IMCR

Catalio Capital Management, LP position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

Catalio Capital Management, LP reported holding 211,985 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$6.4M, representing 1.20% of its reported portfolio and ranking #30 among its reported holdings. Catalio Capital Management, LP has disclosed IMCR holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)211.99K sh
Reported value held$6.42M
Portfolio Weight1.20%
First reportedQ1 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Catalio Capital Management, LP's IMCR position evolved

Catalio Capital Management, LP first disclosed a stake in IMCR in Q1 2026 at 84,352 shares (US$2.5M). The position peaked in Q3 2026 at 211,985 shares, worth US$6.4M. Across 3 filings, Catalio Capital Management, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 211,985 shares valued at US$6.4M — an increase of 63,940 shares quarter over quarter.. Notable position changes include a 76% increase in Q2 2026 (shares fell 5% over the following quarter), a 43% increase in Q3 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 84.35K $2.54M New
Q2 2026 148.04K $4.70M Add
Q3 2026 211.99K $6.42M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 28 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$147.5M), TANG CAPITAL MANAGEMENT LLC (US$87.4M), Bellevue Group AG (US$68.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has Catalio Capital Management, LP held IMCR?

Catalio Capital Management, LP has disclosed IMCR holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Catalio Capital Management, LP's current position in IMCR?

As of Q3 2026, Catalio Capital Management, LP holds 211.99K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $6.42M, representing 1.20% of its reported portfolio and ranking #30.

Has Catalio Capital Management, LP been buying or selling IMCR?

In the latest 13F filing (Q3 2026), Catalio Capital Management, LP increased its position in IMCR. The position peaked in Q3 2026 at 211.99K shares.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, Bellevue Group AG, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.